Provided by Tiger Trade Technology Pte. Ltd.

AIM VACCINE

3.370
+0.0501.51%
Volume:674.00K
Turnover:2.25M
Market Cap:4.13B
PE:-12.97
High:3.400
Open:3.320
Low:3.230
Close:3.320
52wk High:6.550
52wk Low:3.000
Shares:1.23B
HK Float Shares:507.67M
Volume Ratio:2.39
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.260
ROE:-7.39%
ROA:-1.88%
PB:1.10
PE(LYR):-12.97
PS:2.89

Loading ...

AIM VACCINE's Globally First Self-Developed Serum-Free Next-Generation Rabies Vaccine Passes On-Site Registration Inspection

Stock News
·
Feb 05

AIM Vaccine (06660) Passes On-Site Inspection for Serum-Free Iterative Rabies Vaccine

Bulletin Express
·
Feb 05

AIM Vaccine Co. Ltd. Serum-Free Rabies Vaccine Passes On-Site Registration Inspection

Reuters
·
Feb 05

AIM Vaccine - Serum-Free Rabies Vaccine Passes Inspection by Nmpa

THOMSON REUTERS
·
Feb 05

AIM VACCINE (06660) Receives Approval for Clinical Trials of 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Stock News
·
Jan 19

AIM Vaccine - Approval for Clinical Trials of the 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine

THOMSON REUTERS
·
Jan 19

AIM Vaccine Co. Ltd. Receives Approval to Begin Clinical Trials for 20-Valent Pneumococcal Vaccine

Reuters
·
Jan 19

AIM VACCINE (06660): High-Potency Human Diploid Rabies Vaccine with Iterative Process Completes Phase III Clinical On-Site Work

Stock News
·
Jan 15

AIM Vaccine Completes Phase III Clinical Work for High-Potency Rabies Vaccine

Reuters
·
Jan 15

Global Penny Stocks To Watch In January 2026

Simply Wall St.
·
Jan 05

AIM VACCINE (06660): Huang Peiqiao Resigns as Joint Company Secretary

Stock News
·
Dec 31, 2025

AIM Vaccine Appoints Liu as Company Secretary and Authorised Representative

Reuters
·
Dec 31, 2025

AIM Vaccine Co., Ltd. (06660) Releases Monthly Return on Movements in Securities for November 2025

Bulletin Express
·
Dec 01, 2025

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Stock News
·
Nov 18, 2025

AIM Vaccine (06660) Reports No Changes in Registered Share Capital for October 2025

Bulletin Express
·
Nov 03, 2025

RSV Outbreak Drives Surge in Prevention Demand as Companies Race to Capture Infant Market

Deep News
·
Oct 12, 2025

R&D Innovation and Blockbuster Products Drive Multiple Positives, AIM VACCINE (06660) Shows Clear Profit Improvement Logic

Stock News
·
Aug 28, 2025

BRIEF-AIM Vaccine Logs H1 Capex RMB 102.5 Mln

Reuters
·
Aug 27, 2025

AIM Vaccine H1 Gross Profit RMB 341.2 Million

THOMSON REUTERS
·
Aug 27, 2025

AIM Vaccine Co Ltd - Hy Loss Attributable RMB131.1 Mln

THOMSON REUTERS
·
Aug 27, 2025